To elucidate the mechanism by which oral CB‐AKK probiotics inhibit the progression of 4T1 breast tumors, qPCR and immunohistochemistry were performed to assess the expression of genes associated with the Bcl‐2/Bax pathway within tumor tissues. The gene discussed is BCL2; the disease is breast neoplasm.